Triple-negative breast cancer (TNBC), which lacks estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is a highly aggressive subtype of breast cancer. Here, ERBB2 is linked to triple-negative breast carcinoma.